These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31660992)
1. Factors predicting recurrence after curative resection for rectal cancer: a 16-year study. Farhat W; Azzaza M; Mizouni A; Ammar H; Ben Ltaifa M; Lagha S; Kahloul M; Gupta R; Mabrouk MB; Ali AB World J Surg Oncol; 2019 Oct; 17(1):173. PubMed ID: 31660992 [TBL] [Abstract][Full Text] [Related]
2. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection]. Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079 [TBL] [Abstract][Full Text] [Related]
3. Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Patel SA; Chen YH; Hornick JL; Catalano P; Nowak JA; Zukerberg LR; Bleday R; Shellito PC; Hong TS; Mamon HJ Dis Colon Rectum; 2014 Apr; 57(4):449-59. PubMed ID: 24608301 [TBL] [Abstract][Full Text] [Related]
4. Indication and benefit of pelvic sidewall dissection for rectal cancer. Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749 [TBL] [Abstract][Full Text] [Related]
5. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer. Chang SC; Lin JK; Yang SH; Jiang JK; Chen WC; Lin TC Hepatogastroenterology; 2003; 50(54):1898-902. PubMed ID: 14696429 [TBL] [Abstract][Full Text] [Related]
7. Surgeon-related factors and outcome in rectal cancer. Porter GA; Soskolne CL; Yakimets WW; Newman SC Ann Surg; 1998 Feb; 227(2):157-67. PubMed ID: 9488510 [TBL] [Abstract][Full Text] [Related]
8. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery. Zeng WG; Liu MJ; Zhou ZX; Wang ZJ Dis Colon Rectum; 2017 Nov; 60(11):1175-1183. PubMed ID: 28991082 [TBL] [Abstract][Full Text] [Related]
9. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974 [TBL] [Abstract][Full Text] [Related]
10. Radiologic Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer After Lateral Pelvic Lymph Node Dissection. Shiraishi T; Sasaki T; Tsukada Y; Ikeda K; Nishizawa Y; Ito M Dis Colon Rectum; 2021 Dec; 64(12):1479-1487. PubMed ID: 34657076 [TBL] [Abstract][Full Text] [Related]
11. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy. Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054 [TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of adenocarcinoma of the rectum. Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543 [TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]
15. Time to local recurrence as a prognostic factor in patients with rectal cancer. Westberg K; Palmer G; Johansson H; Holm T; Martling A Eur J Surg Oncol; 2015 May; 41(5):659-66. PubMed ID: 25749391 [TBL] [Abstract][Full Text] [Related]
16. The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma. Silva-Velazco J; Stocchi L; Valente MA; Church JM; Liska D; Gorgun E; Kalady MF; Kessler H; Steele SR; Delaney CP Colorectal Dis; 2019 Mar; 21(3):315-325. PubMed ID: 30565830 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer. Leite JS; Martins SC; Oliveira J; Cunha MF; Castro-Sousa F Colorectal Dis; 2011 Apr; 13(4):381-6. PubMed ID: 20002696 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. Kobayashi H; Mochizuki H; Morita T; Kotake K; Teramoto T; Kameoka S; Saito Y; Takahashi K; Hase K; Oya M; Maeda K; Hirai T; Kameyama M; Shirouzu K; Sugihara K J Gastroenterol; 2011 Feb; 46(2):203-11. PubMed ID: 21152938 [TBL] [Abstract][Full Text] [Related]
19. Results of radical surgery for rectal cancer. Heald RJ; Karanjia ND World J Surg; 1992; 16(5):848-57. PubMed ID: 1462619 [TBL] [Abstract][Full Text] [Related]
20. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. Madbouly KM; Abbas KS; Hussein AM Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]